1. Home
  2. CINT vs VSTM Comparison

CINT vs VSTM Comparison

Compare CINT & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$3.25

Market Cap

478.1M

Sector

Technology

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$5.49

Market Cap

395.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
VSTM
Founded
1995
2010
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.1M
395.4M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
CINT
VSTM
Price
$3.25
$5.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$7.35
$16.50
AVG Volume (30 Days)
218.2K
3.0M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$30,914,000.00
Revenue This Year
$16.69
$282.64
Revenue Next Year
$11.28
$72.25
P/E Ratio
$17.94
N/A
Revenue Growth
N/A
209.14
52 Week Low
$3.16
$3.43
52 Week High
$6.06
$11.25

Technical Indicators

Market Signals
Indicator
CINT
VSTM
Relative Strength Index (RSI) 39.49 72.07
Support Level $3.16 $4.99
Resistance Level $5.01 $6.80
Average True Range (ATR) 0.23 0.41
MACD -0.02 0.21
Stochastic Oscillator 7.25 96.50

Price Performance

Historical Comparison
CINT
VSTM

About CINT CI&T Inc

CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: